A Phase 1 Double Blind (3rd Party Open) Randomized, Placebo Controlled, Dose Escalation Study To Investigate The Safety,Tolerability, Pharmacokinetics And Pharmacodynamics Of Repeat Doses Of PF-06743649 With Or Without Food In Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2016
Price : $35 *
At a glance
- Drugs PF 6743649 (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Pfizer
- 18 Jan 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Dec 2014 Planned End Date changed from 1 Nov 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov.